Overview and Chemical Properties

1-Phenyl-2-(chloromethyl)-1H-benzimidazole (SKU: P729768) belongs to the benzimidazole class of bicyclic aromatic heterocycles, consisting of a benzene ring fused to an imidazole ring. The N1 position bears a phenyl substituent, while the C2 position carries a reactive chloromethyl (–CH₂Cl) group. This combination of a stable, electron-rich aromatic scaffold with a reactive electrophilic handle makes the compound a valuable intermediate in the preparation of diverse benzimidazole-based compounds.

The chloromethyl group is susceptible to nucleophilic substitution (S_N2) reactions with a broad range of nucleophiles including amines, thiols, alkoxides, and carbanions, enabling rapid diversification of the benzimidazole scaffold. Benzimidazole derivatives are well-recognized in medicinal chemistry for their appearance in antiparasitic, antifungal, antiviral, and anticancer agents.

Safety and Handling Precautions

As a chloromethyl-containing compound, 1-Phenyl-2-(chloromethyl)-1H-benzimidazole should be handled with appropriate care. Alkyl chlorides in general are potential irritants and may be lachrymatory. The following precautions are recommended:

• Personal Protective Equipment (PPE): Wear nitrile gloves, a laboratory coat, and safety goggles at all times when handling this compound.
• Ventilation: All weighing and reaction operations should be performed in a chemical fume hood to prevent inhalation of dust or vapors.
• Skin and Eye Contact: Avoid direct contact. In case of skin contact, wash thoroughly with soap and water. In case of eye contact, rinse immediately with copious amounts of water and seek medical attention.
• Storage: Store in a tightly sealed container in a cool, dry, and well-ventilated area, away from moisture, strong bases, and strong oxidizing agents.
• Disposal: Dispose of waste in accordance with local institutional and governmental regulations for halogenated organic waste.

Consult the Safety Data Sheet (SDS) for this product before use and follow all applicable laboratory safety protocols.

Solubility and Solution Preparation Protocol

Proper dissolution is critical for reproducible results in downstream reactions. Follow this protocol to prepare stock and working solutions:

1. Solvent Selection: 1-Phenyl-2-(chloromethyl)-1H-benzimidazole is expected to be soluble in common polar aprotic organic solvents such as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dichloromethane (DCM), acetonitrile (MeCN), and tetrahydrofuran (THF). Avoid protic solvents (e.g., water, alcohols) for stock solutions, as the chloromethyl group may undergo slow hydrolysis or solvolysis under these conditions.
2. Stock Solution Preparation: Weigh the desired quantity of compound using a calibrated analytical balance inside a fume hood. Transfer to a clean, dry glass vial. Add the chosen anhydrous solvent incrementally and mix by gentle vortexing or stirring until complete dissolution is achieved. Prepare stock solutions at a concentration of 0.1–0.5 M for synthetic applications.
3. Filtration (if required): If insoluble particles are observed, filter through a 0.2 µm PTFE syringe filter before use.
4. Immediate Use: Freshly prepared solutions are recommended. If storage is necessary, seal vials under inert gas (N₂ or Ar), wrap with Parafilm, and store at –20 °C in the dark for short periods.

Note: Verify solubility empirically for each new lot and application, as observed solubility may vary with purity and particle size.

Representative Synthetic Application Protocol

The chloromethyl group at C2 of the benzimidazole ring renders this compound useful as an electrophilic partner in nucleophilic substitution reactions. The following general protocol illustrates its use in N-alkylation or S-alkylation reactions with heteroatom nucleophiles:

General N-Alkylation / S-Alkylation Protocol

1. Materials: 1-Phenyl-2-(chloromethyl)-1H-benzimidazole (1.0 equiv), nucleophile (amine, thiol, or other; 1.0–1.2 equiv), base (e.g., K₂CO₃, Cs₂CO₃, or Et₃N; 1.5–2.0 equiv), anhydrous solvent (DMF, MeCN, or acetone), inert atmosphere (N₂ or Ar).
2. Procedure:
   1. Charge a dry round-bottom flask with a magnetic stir bar. Add the nucleophile and base to the flask.
   2. Dissolve 1-Phenyl-2-(chloromethyl)-1H-benzimidazole in a minimum volume of anhydrous solvent and add dropwise to the reaction vessel at room temperature or 0 °C.
   3. Stir the reaction mixture at room temperature to 80 °C (temperature depends on nucleophile reactivity) and monitor by TLC or HPLC until starting material consumption is observed.
   4. Upon completion, dilute the reaction with ethyl acetate or DCM, wash with water and brine, dry over anhydrous MgSO₄ or Na₂SO₄, filter, and concentrate under reduced pressure.
   5. Purify the crude product by column chromatography (silica gel) or recrystallization.
3. Analysis: Confirm product identity by ¹H NMR, ¹³C NMR, and mass spectrometry. The disappearance of the –CH₂Cl methylene signal (typically ~4.8–5.2 ppm in ¹H NMR) and appearance of a new –CH₂–Nu signal confirms successful alkylation.

Reaction conditions (temperature, solvent, base, and stoichiometry) should be optimized for each specific nucleophile and target compound.

Quality Control and Analytical Characterization

Prior to use in sensitive synthetic or biological applications, analysts should verify the identity and purity of 1-Phenyl-2-(chloromethyl)-1H-benzimidazole using the following methods:

• Thin-Layer Chromatography (TLC): Run on silica gel plates with an appropriate eluent (e.g., hexane/ethyl acetate mixtures). Visualize under UV light (254 nm). A single spot at the expected R_f value indicates acceptable purity for most synthetic purposes.
• HPLC Purity Analysis: Reverse-phase HPLC (C18 column, acetonitrile/water gradient with 0.1% TFA) can be used to quantify purity. A purity of ≥95% (peak area) is typically required for medicinal chemistry applications.
• ¹H NMR Characterization: Key signals include aromatic protons in the 7.2–8.0 ppm region and the characteristic –CH₂Cl methylene signal expected at approximately 4.8–5.2 ppm. The exact chemical shift should be confirmed against literature or in-house reference data.
• Mass Spectrometry: Confirm molecular ion [M+H]⁺ or [M+Na]⁺ consistent with the molecular formula. The characteristic isotope pattern from chlorine (3:1 ratio of M:M+2) provides additional confirmation.
• Melting Point: Determination of melting point and comparison with supplier certificate of analysis values is a simple identity check.

All analytical data should be recorded in a laboratory notebook and archived with the batch record for traceability.